Stocks and Investing Stocks and Investing
Wed, May 18, 2022
Tue, May 17, 2022

Andrew Berens Maintained (AGIO) at Hold with Increased Target to $33 on, May 17th, 2022


Published on 2024-10-27 21:08:34 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Hold with Increased Target from $30 to $33 on, May 17th, 2022.

Andrew has made no other calls on AGIO in the last 4 months.



There are 4 other peers that have a rating on AGIO. Out of the 4 peers that are also analyzing AGIO, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Andrew


  • Salveen Richter of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $23 on, Monday, March 7th, 2022
  • Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $96 on, Thursday, March 3rd, 2022
  • Kennen MacKay of "RBC Capital" Maintained at Buy with Increased Target to $67 on, Friday, February 25th, 2022
  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $44 on, Wednesday, February 16th, 2022
Contributing Sources